ResearcherIkerbasqueNo recent work listed

Ander Matheu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1848-0781; OpenAlex author ID A5015885258. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression. Last author DOI 10.3390/cancers14040916 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Manuel Collado · 1 shared paper, 2022 · strength 0.13
- Paper SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression. DOI 10.3390/cancers14040916 ↗
Estefanía Carrasco‐García · 1 shared paper, 2022 · strength 0.13
- Paper SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression. DOI 10.3390/cancers14040916 ↗
Manuel M. Hidalgo · 1 shared paper, 2022 · strength 0.13
- Paper SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression. DOI 10.3390/cancers14040916 ↗
Eva Karamitopoulou · 1 shared paper, 2022 · strength 0.13
- Paper SOX9 Triggers Different Epithelial to Mesenchymal Transition States to Promote Pancreatic Cancer Progression. DOI 10.3390/cancers14040916 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.